Posts
Media
Videos
Starter Packs
Reposted by ATS PITB Assembly
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 27
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis | NEJM
In bronchiectasis, neutrophilic inflammation is associated with an increased risk
of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor
of dipeptidyl peptidase 1 (DPP...
www.nejm.org
Reposted by ATS PITB Assembly
Reposted by ATS PITB Assembly
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 19
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 18
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 18
British Thoracic Society Clinical Statement on Aspergillus-related chronic lung disease
Aspergillus spp. cause a wide range of acute, sub-acute and chronic lung conditions, some of which can lead to progressive loss of lung function and death. More extensive use of immunosuppression in m...
thorax.bmj.com
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 15
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial - Nature Communications
Vaccination provides protection from COVID-19, but optimization in design and route is an ever-ongoing process. Here the authors pursue an open-label, multi-arm phase I clinical trial to report the sa...
www.nature.com
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 15
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis | NEJM
In bronchiectasis, neutrophilic inflammation is associated with an increased risk
of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor
of dipeptidyl peptidase 1 (DPP...
www.nejm.org
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 15
Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015–2019
Individuals surviving tuberculosis (TB) disease may experience chronic sequelae that reduce survival and quality of life. These post-TB sequalae are not generally considered in estimates of the health...
pmc.ncbi.nlm.nih.gov
ATS PITB Assembly
@ats-pitb.bsky.social
· Aug 10
Psychological stress and health-related quality of life among tuberculosis patients: a prospective cohort study
Economic, social and psychological distress is common in individuals affected by tuberculosis (TB). However, the magnitude of distress, psychological interventions and their effect on the treatment outcomes are often under-evaluated. We examined the level of psychological stress and health-related quality of life (HRQoL) of such patients and the effect of antituberculosis therapy on them. Our prospective cohort study included newly diagnosed adult pulmonary and extrapulmonary TB patients. Assessment of psychological stress was done using the seven-item Generalised Anxiety Disorder questionnaire for anxiety and the nine-item Patient Health Questionnaire for depression. HRQoL was assessed by using the WHOQOL-BREF questionnaire. Of the 86 patients studied, 21 (24.4%) had anxiety symptoms at the baseline, which reduced to 5.8% and 1.2% at 2 months and treatment completion, respectively (p<0.001). Among the subjects, 18 (20.9%) patients had depression, which reduced to 7% and 2.3% at 2 months and treatment completion, respectively (p<0.001). All the mean domain scores of HRQoL were poor at the baseline, which showed improvement at treatment completion (p<0.001). Anxiety and depression were common among TB patients, and there was significant progressive reduction during and after treatment. TB had remarkable negative impacts on HRQoL, with the physical domain being the most affected, and all the domain scores showed significant improvement at treatment completion. Routine screening for depression and anxiety and timely referral to a psychiatrist are required in TB patients to improve the outcome of the disease and quality of life.
publications.ersnet.org